|Videos|April 27, 2023
Interview with Scorpius BioManufacturing’s Steven Lavezoli
Author(s)Scorpius BioManufacturing
Key Learning Objectives:
- Demonstrate that Scorpius has the expertise to bring large molecule drugs to the clinic
- Make the industry aware we have immediately available capacity
- Explain how Scorpius values the client-CDMO partnership
Related Content
Trending on Pharmaceutical Technology
1
Peptide Compounding Vote Raises New Questions for Drug Developers
2
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
3
PharmTech Weekly Roundup—July 24, 2026
4
Q&A : Brent Wilhelm on Supply Chains and Historical Demand Data
5